| 1 |
林华胜，张薇，李国明. 肺炎克雷伯菌耐药机制的研究进展[J]. 中国医学创新, 2014, 4(12):151-153.
|
| 2 |
周蓉，朱卫民. 肺炎克雷伯菌分子流行病学及耐药机制研究进展[J]. 国外医药抗生素册, 2012, 3(1):1-5.
|
| 3 |
Cai W, Fu Y, Zhang W, et al. Synergistic effects of baicalein withcefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression[J]. BMC Microbiology, 2016, 16(1):181-189.
|
| 4 |
Shaikh S, Rizvi S, Anis R, et al. Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin[J]. Lett Appl Microbiol, 2016,62 (5):419-427.
|
| 5 |
国家卫生计生委合理用药专家委员会. 2015年全国细菌耐药监测报告. 中国执业药师, 2016,3:3-8.
|
| 6 |
Minarini LA, GalesAC, Palazzo IC, et al. Prevalence of community occurring extended spebetrum beta-lactamases producing Enterobacteriaceae in Brazil[J]. Curr Microbiol, 2007,54(5):335-341.
|
| 7 |
Ouedraogo AS, Sanou M, Kissou A, et al. High prevalence of extended-spectrumß-lactamase producing enterobacteriaceaeamong clinical isolates in Burkina Faso[J]. BMC Infectious Dis, 2016,16:326.
|
| 8 |
张戡，邓敏，谢新生，等. 产AmpC肺炎克雷伯菌质粒介导的多药耐药性与基因型研究[J]. 中医院感染学杂志, 2016,26(1):7-9.
|
| 9 |
Lee CR, Lee JH, Park KS, et al. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae:Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front Microbiol, 2016,7:895.
|
| 10 |
刘婧娴，俞静，李媛睿，等. 肺炎克雷伯菌对碳青霉烯类抗生素的耐药机制研究[J]. 上海交通大学学报医学版, 2016,36(1):93-99.
|
| 11 |
Yong D, Toleman MA, Giske CG, et al. Characterization of a New Metallo-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique GeneticStructure in Klebsiellapneumoniae Sequence Type 14 from India[J].Antimicrob Agents Chemother, 2009,53(12):5046-5054.
|
| 12 |
Adler A, Miller-Roll T, Assous MV, et al. A multicenter study of the clonal structure and resistance mechanismof KPC-producing Escherichia coli isolates in Israel[J]. Clin Microbiol Infect, 2015,21(3):230-235.
|
| 13 |
Shi W, Li K, Ji Y，et al．Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porinOmp K36 loss and DHA-1β-lactamase production[J]. Braz J Microbiol, 2013,44(2):435-442.
|
| 14 |
Briales A, Rodríguez-Martínez JM, Velasco C, et al. Velasco CPrevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6ʹ)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain[J]. Int J Antimicrob Agents, 2012,39 (5):431-435.
|
| 15 |
姜梅杰. 肺炎克雷伯菌质粒介导喹诺酮类耐药基因qnrA、qnrB和qnrS的研究[J/CD]. 中华临床医师杂志:电子版, 2011,5(23):7136-7139.
|
| 16 |
李从荣，黄俊，李艳. 质粒介导喹诺酮耐药基因-qnr的流行现状及耐药研究[A]. 中华医学会第七次全国检验医学学术会议资料汇编[C], 2008.
|
| 17 |
Bado I, Gutiérrez C, García-Fulgueiras V, et al. CTX-M-15 in combination with aac(6ʹ)-Ib-cr is the most prevalent mechanism of resistance both in Escherichia coli and Klebsiella pneumoniae, including K. pneumoniae ST258, in an ICU in Uruguay[J]. J Glob Antimicrob Resist, 2016,6:5-9.
|
| 18 |
杨名保，邱书奇，柯朝阳. 细菌生物膜及其相关感染的研究进展[J/CD]. 中华临床医师杂志:电子版, 2011,5(9):2675-2676.
|
| 19 |
杨朵，马东媛，王松雪，等. 肺炎克雷伯菌生物膜与细菌耐药性的关系分析[J].中华医院感染学杂志, 2013,23(12):2785-2786.
|
| 20 |
Bialek-Davenet S, Lavigne JP, Guyot K, et al. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumonia[J]. J Antimicrob Chemother, 2015,70(1): 81-88.
|
| 21 |
龚文胜，吴劲松，张为民. 肺炎克雷伯菌耐药性与I类整合子关系的研究[J]. 中国微生态学杂志, 2014,26(2):166-168.
|
| 22 |
Doorduijn DJ, Rooijakkers SH, van Schaik W, et al. Complement resistance mechanisms of Klebsiella pneumonia Dennis [J]. Immunobiology, 2016,221(10):1102-1109.
|